MEDICED, ALLIS MEDICATED MEDICATION: A story about medicated or nonmedication medical equipment.MEDICED WIZ: Medical and nonmedical devices that help people.

Allis Medical Instrument is a medical device company that manufactures and sells devices to assist people with conditions including pain and spasticity, arthritis, asthma, heart disease, neurological disorders, and multiple sclerosis.

Allis has a global network of over 1,000 employees and has an operating facility in Toronto, Ontario.

In 2018, Allis reported sales of over $2 billion, according to the Canadian Association of Medical Instrument Manufacturers.

The company employs about 8,000 people and produces over 8,500 medical devices.

Its innovative technology helps people manage their health with a single device that is powered by a simple push of a button.

Alli’s products have been used by the Canadian Armed Forces, Royal Canadian Mounted Police, and Royal Ontario Museum to monitor heart rate and respiratory health.

All the products are made in Ontario and have been approved for use in the United States.

In 2017, Alli received the Canada Innovation Award for innovation.

The award was presented by the National Medical Association of Canada.

Allistair Wootton, president of Allis, said that the company has received more than 400 awards from the medical device industry.

“We are thrilled to have been recognized for our continued excellence in medical devices and innovative technology for the healthcare community, including the Medical Device Award, the Innovation Award, and the National Health and Medical Technology Awards,” said Wootston.

The Allis Medical Instruments award was announced at the 2017 Canada Innovations Awards ceremony.

All is also a member of the Canadian Medical Devices Alliance, a group of industry associations that includes Allis and several others.

In 2018, a collaboration between Allis International, which manufactures Allis medicated devices, and a leading healthcare company led to a significant reduction in drug-resistant bacteria in the community, Allie Housley, a research scientist at Allis told CBC News.

“There’s a lot of research and data on how these drugs can be administered and how they are actually used.”

In 2018 Allis Medicated, Allistar and other medical devices were the subject of a new study.

The study by researchers at the University of Waterloo in Ontario focused on the effects of administering a drug that has a unique combination of properties to reduce the risk of drug resistance.

Researchers said they found the drug can reduce drug resistance by 30 percent.

Allie said this could be a huge breakthrough in how to treat a wide range of illnesses.

“We have a really big gap in our understanding of how to effectively treat these diseases and how to prevent their recurrence,” she said.

“What this is really saying is that our ability to fight these diseases is not just about our drugs, but about our technology.”

The research was funded by the Wellcome Trust and the Canadian Institutes of Health Research.